Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus Carlo Amorin DaepJorge L. Muñoz-JordánEliseo Alberto Eugenin Review 07 October 2014 Pages: 539 - 560
Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment Jordan E. CattieScott L. LetendreThe Translational Methamphetamine AIDS Research Center (TMARC) Group OriginalPaper 18 October 2014 Pages: 561 - 570
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND) Lishomwa C. NdhlovuTracie UmakiCecilia M. Shikuma OriginalPaper 17 September 2014 Pages: 571 - 582
Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) Carlos VilchezMassiel Gonzalez-ReinosoPeter Stoeter OriginalPaper 17 September 2014 Pages: 583 - 590
Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease Kelly A. MeulendykeSuzanne E. QueenM. Christine Zink OriginalPaper 17 September 2014 Pages: 591 - 602
Brain morphometric correlates of metabolic variables in HIV: the CHARTER study S. L. ArchibaldJ. A. McCutchanfor the CHARTER Group OriginalPaper 17 September 2014 Pages: 603 - 611
Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb Chun-Xia LiXiaodong ZhangFrancis J. Novembre OriginalPaper 07 November 2014 Pages: 612 - 619
Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment Ned SacktorSachiko Miyaharaon behalf of the ACTG A5235 team OriginalPaper 07 November 2014 Pages: 620 - 626
Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease Robert H. PaulJohn A. JoskaDan J. Stein OriginalPaper 01 November 2014 Pages: 627 - 635
Human T-lymphotropic virus type 2 subtype b in a patient with chronic neurological disorder Carolina RosadasAna C. P. VicenteMarzia Puccioni-Sohler Case Report 03 September 2014 Pages: 636 - 639
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man Joshua ChalkleyJoseph R. Berger Case Report 01 November 2014 Pages: 640 - 643
2014 Colorado alphaherpesvirus latency symposium Randall J. CohrsDon Gilden Guest Editorial 05 November 2014 Pages: 644 - 656